Media headlines about Inovalon Holdings (NASDAQ:INOV) have trended somewhat positive on Friday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Inovalon Holdings earned a news impact score of 0.07 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 47.7808027324294 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news stories that may have effected Accern’s analysis:

Inovalon Holdings (INOV) traded up $0.20 during trading hours on Friday, hitting $15.35. 258,293 shares of the stock were exchanged, compared to its average volume of 450,588. The company has a quick ratio of 5.62, a current ratio of 5.62 and a debt-to-equity ratio of 0.31. Inovalon Holdings has a one year low of $8.60 and a one year high of $17.80. The company has a market cap of $2,260.00 and a P/E ratio of 73.33.

Inovalon Holdings (NASDAQ:INOV) last issued its quarterly earnings results on Wednesday, November 1st. The technology company reported $0.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.01. Inovalon Holdings had a return on equity of 4.63% and a net margin of 4.07%. The firm had revenue of $115.90 million during the quarter, compared to analyst estimates of $114.79 million. During the same period last year, the company earned $0.10 EPS. Inovalon Holdings’s quarterly revenue was up 10.4% compared to the same quarter last year. equities research analysts predict that Inovalon Holdings will post 0.24 earnings per share for the current fiscal year.

A number of analysts recently weighed in on INOV shares. Morgan Stanley upgraded shares of Inovalon Holdings from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $9.00 to $14.00 in a report on Tuesday, September 12th. TheStreet upgraded shares of Inovalon Holdings from a “d+” rating to a “c-” rating in a report on Thursday, October 5th. ValuEngine upgraded shares of Inovalon Holdings from a “sell” rating to a “hold” rating in a report on Wednesday, September 6th. KeyCorp restated a “hold” rating on shares of Inovalon Holdings in a research report on Tuesday, September 12th. Finally, BidaskClub downgraded shares of Inovalon Holdings from a “buy” rating to a “hold” rating in a research report on Friday, August 11th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $14.00.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at

In other Inovalon Holdings news, CEO Keith R. Dunleavy bought 62,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were purchased at an average cost of $16.38 per share, for a total transaction of $1,015,560.00. Following the purchase, the chief executive officer now directly owns 270,000 shares in the company, valued at $4,422,600. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 48.28% of the company’s stock.

Inovalon Holdings Company Profile

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon Holdings (NASDAQ:INOV)

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with's FREE daily email newsletter.